LENZ Therapeutics adds China partner for presbyopia drug VIZZ
LENZ Therapeutics Inc LENZ
$6.15
▼ -3.00%
($-0.19)
Open
$6.38
Prev Close
$6.34
Day Range
$5.84 – $6.55
52W Range
$6.29 – $50.40
Market Cap
$192.83M
Beta
2.02
EPS (TTM)
$-3.59
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-06-25 |
| Shares Out. | 31,350,000 |
| Website | lenz-tx.com/ ↗ |
| Phone | 18589257000 |
LENZ Therapeutics Inc is a publicly traded company under the ticker symbol LENZ on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-06-01)